Wikidata

(Q62041787)

English

Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma

clinical trial

In more languages
default for all languages
No label defined

No description defined

Statements

title
Safety and Efficacy of IM21 Car-t Cells in Patients With Recurrent or Refractory BCMA Positive Multiple Myeloma (English)
0 references
start time
10 October 2018
0 references
end time
10 October 2020
0 references
number of participants
15
0 references
minimum age
18 year
0 references
maximum age
80 year
0 references

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q62041787&oldid=2148527431"